Lung cancer is the leading cause of cancer-related death in the U.S. and worldwide.
The number of deaths from lung cancer continues to rise and is more frequent than the next four most common sites combined—colon, breast, prostate and pancreas. Martha Jefferson's five-year survival rate for lung cancer is superior to state and national averages.
Of the most commonly diagnosed and treated cancers, lung cancer is the most challenging in terms of long-term survival. This challenge is related to the stage at which the cancer is often found. Symptoms typically do not appear until the disease is advanced, and when it is found in the earlier stages, it is often as a byproduct of imaging tests performed for another reason.
At Martha Jefferson, a multidisciplinary and multi modality approach to lung cancer provides patients with exceptional quality care and attention. Anatomic and clinical pathologists provide timely diagnosis, staging and treatment. State-of-the-art imaging services provide the support needed to evaluate the cancer and the patient’s overall health.
Multimodality treatments are provided by experienced medical and radiation oncology physicians. Sophisticated technologies allow radiation oncologists to plan optimal therapy to the tumor and spare surrounding tissue. Excellent medical oncologists specialize in systemic treatment of lung cancer using current standards of chemotherapy. Advanced surgical techniques are also offered.
Exciting new treatments for lung cancer are continually being explored. Martha Jefferson Hospital will remain on the cutting edge of these advances, providing the best possible care for lung cancer patients in Central Virginia. The following is a partial list of services: